Progress to Therapy 2012 will cover the science, clinical need, regulatory environment, supporting technologies and government engagement.
Progress to Therapy 2012 is an interdisciplinary event bringing together international experts to share knowledge and experience with the aim of accelerating Progress to Therapy in Regenerative Medicine.
Progress to Therapy 2012 is aimed at anyone who has a professional interest in regenerative medicine, for example scientists, clinicians, patient groups, health economists, policy advocates, regulatory experts, etc.
Day 1 of the conference will focus on therapies for cardiovascular disease.
Day 2 and 3 will examine a range of Advanced Therapeutic Medicinal Products (ATMPs),and address key issues in clinical trials, regulation, imaging, manufacturing, reimbursement and business models.
This conference is an event organised by the Scottish Stem Cell Network (SSCN) which is a Scottish Enterprise subsidiary company working to create a globally connected Regenerative Medicine community.
